309 related articles for article (PubMed ID: 26033735)
61. Oxacillin sensitization of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius by antisense peptide nucleic acids in vitro.
Goh S; Loeffler A; Lloyd DH; Nair SP; Good L
BMC Microbiol; 2015 Nov; 15():262. PubMed ID: 26560174
[TBL] [Abstract][Full Text] [Related]
62. Evaluation of vancomycin and daptomycin MIC trends for methicillin-resistant Staphylococcus aureus blood isolates over an 11 year period.
Sancak B; Yagci S; Mirza HC; Hasçelik G
J Antimicrob Chemother; 2013 Nov; 68(11):2689-91. PubMed ID: 23788481
[No Abstract] [Full Text] [Related]
63. Mechanism of action of the cell-division inhibitor PC190723: modulation of FtsZ assembly cooperativity.
Elsen NL; Lu J; Parthasarathy G; Reid JC; Sharma S; Soisson SM; Lumb KJ
J Am Chem Soc; 2012 Aug; 134(30):12342-5. PubMed ID: 22793495
[TBL] [Abstract][Full Text] [Related]
64. In vitro activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics.
Kaplan N; Awrey D; Bardouniotis E; Berman J; Yethon J; Pauls HW; Hafkin B
J Chemother; 2013 Feb; 25(1):18-25. PubMed ID: 23433440
[TBL] [Abstract][Full Text] [Related]
65. Antisense growth inhibition of methicillin-resistant Staphylococcus aureus by locked nucleic acid conjugated with cell-penetrating peptide as a novel FtsZ inhibitor.
Meng J; Da F; Ma X; Wang N; Wang Y; Zhang H; Li M; Zhou Y; Xue X; Hou Z; Jia M; Luo X
Antimicrob Agents Chemother; 2015 Feb; 59(2):914-22. PubMed ID: 25421468
[TBL] [Abstract][Full Text] [Related]
66. A bactericidal guanidinomethyl biaryl that alters the dynamics of bacterial FtsZ polymerization.
Kaul M; Parhi AK; Zhang Y; LaVoie EJ; Tuske S; Arnold E; Kerrigan JE; Pilch DS
J Med Chem; 2012 Nov; 55(22):10160-76. PubMed ID: 23050700
[TBL] [Abstract][Full Text] [Related]
67. Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus.
Eissa IH; Mohammad H; Qassem OA; Younis W; Abdelghany TM; Elshafeey A; Abd Rabo Moustafa MM; Seleem MN; Mayhoub AS
Eur J Med Chem; 2017 Apr; 130():73-85. PubMed ID: 28249208
[TBL] [Abstract][Full Text] [Related]
68. Point: Vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus.
Mohr JF; Murray BE
Clin Infect Dis; 2007 Jun; 44(12):1536-42. PubMed ID: 17516395
[TBL] [Abstract][Full Text] [Related]
69. Use of Translational Pharmacokinetic/Pharmacodynamic Infection Models To Understand the Impact of Neutropenia on the Efficacy of Tedizolid Phosphate.
Xiao J; Gill C; Liang L; Liu J; Wu J; Feng HP; Flanagan S; Tan C; Flattery A
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373794
[TBL] [Abstract][Full Text] [Related]
70. Madurahydroxylactone, an Inhibitor of
Kim BM; Choi HY; Kim GW; Zheng CJ; Kim YH; Kim WG
J Microbiol Biotechnol; 2017 Nov; 27(11):1994-1998. PubMed ID: 28910864
[TBL] [Abstract][Full Text] [Related]
71. Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureus.
Wicha SG; Kees MG; Kuss J; Kloft C
Pharm Res; 2015 Jul; 32(7):2410-8. PubMed ID: 25630818
[TBL] [Abstract][Full Text] [Related]
72. The antibacterial cell division inhibitor PC190723 is an FtsZ polymer-stabilizing agent that induces filament assembly and condensation.
Andreu JM; Schaffner-Barbero C; Huecas S; Alonso D; Lopez-Rodriguez ML; Ruiz-Avila LB; Núñez-Ramírez R; Llorca O; Martín-Galiano AJ
J Biol Chem; 2010 May; 285(19):14239-46. PubMed ID: 20212044
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
Shahin IG; Abutaleb NS; Alhashimi M; Kassab AE; Mohamed KO; Taher AT; Seleem MN; Mayhoub AS
Eur J Med Chem; 2020 Sep; 202():112497. PubMed ID: 32707373
[TBL] [Abstract][Full Text] [Related]
74. Boosting the efficacy of anti-MRSA β-lactam antibiotics via an easily accessible, non-cytotoxic and orally bioavailable FtsZ inhibitor.
Lui HK; Gao W; Cheung KC; Jin WB; Sun N; Kan JWY; Wong ILK; Chiou J; Lin D; Chan EWC; Leung YC; Chan TH; Chen S; Chan KF; Wong KY
Eur J Med Chem; 2019 Feb; 163():95-115. PubMed ID: 30503946
[TBL] [Abstract][Full Text] [Related]
75. Exebacase Is Active
Swift SM; Sauve K; Cassino C; Schuch R
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0272320. PubMed ID: 34228536
[TBL] [Abstract][Full Text] [Related]
76. Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity.
Kotb A; Abutaleb NS; Seleem MA; Hagras M; Mohammad H; Bayoumi A; Ghiaty A; Seleem MN; Mayhoub AS
Eur J Med Chem; 2018 May; 151():110-120. PubMed ID: 29605807
[TBL] [Abstract][Full Text] [Related]
77. Novel two-chain fatty acid-based lipids for development of vancomycin pH-responsive liposomes against
Makhathini SS; Kalhapure RS; Jadhav M; Waddad AY; Gannimani R; Omolo CA; Rambharose S; Mocktar C; Govender T
J Drug Target; 2019 Dec; 27(10):1094-1107. PubMed ID: 30901236
[TBL] [Abstract][Full Text] [Related]
78. Novel FtsZ inhibitor with potent activity against Staphylococcus aureus.
Kumar M; Mathur T; Barman TK; Chaira T; Kumar R; Joshi V; Pandya M; Sharma L; Fujii K; Bandgar M; Jadhav B; Bambal R; Upadhyay D; Masuda N; Verma AK; Bhatnagar PK
J Antimicrob Chemother; 2021 Oct; 76(11):2867-2874. PubMed ID: 34383913
[TBL] [Abstract][Full Text] [Related]
79. Inhibiting the growth of methicillin-resistant Staphylococcus aureus in vitro with antisense peptide nucleic acid conjugates targeting the ftsZ gene.
Liang S; He Y; Xia Y; Wang H; Wang L; Gao R; Zhang M
Int J Infect Dis; 2015 Jan; 30():1-6. PubMed ID: 25447735
[TBL] [Abstract][Full Text] [Related]
80. Structural Flexibility of an Inhibitor Overcomes Drug Resistance Mutations in Staphylococcus aureus FtsZ.
Fujita J; Maeda Y; Mizohata E; Inoue T; Kaul M; Parhi AK; LaVoie EJ; Pilch DS; Matsumura H
ACS Chem Biol; 2017 Jul; 12(7):1947-1955. PubMed ID: 28621933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
